Two Variants in SLC24A5 Are Associated with “Tiger-Eye” Iris Pigmentation in Puerto Rican Paso Fino Horses

A unique eye color, called tiger-eye, segregates in the Puerto Rican Paso Fino (PRPF) horse breed and is characterized by a bright yellow, amber, or orange iris. Pedigree analysis identified a simple autosomal recessive mode of inheritance for this trait. A genome-wide association study (GWAS) with 24 individuals identified a locus on ECA 1 reaching genome-wide significance (Pcorrected = 1.32 × 10−5). This ECA1 locus harbors the candidate gene, Solute Carrier Family 24 (Sodium/Potassium/Calcium Exchanger), Member 5 (SLC24A5), with known roles in pigmentation in humans, mice, and zebrafish. Humans with compound heterozygous mutations in SLC24A5 have oculocutaneous albinism (OCA) type 6 (OCA6), which is characterized by dilute skin, hair, and eye pigmentation, as well as ocular anomalies. Twenty tiger-eye horses were homozygous for a nonsynonymous mutation in exon 2 (p.Phe91Tyr) of SLC24A5 (called here Tiger-eye 1), which is predicted to be deleterious to protein function. Additionally, eight of the remaining 12 tiger-eye horses heterozygous for the p.Phe91Tyr variant were also heterozygous for a 628 bp deletion encompassing all of exon 7 of SLC24A5 (c.875-340_1081+82del), which we will call here the Tiger-eye 2 allele. None of the 122 brown-eyed horses were homozygous for either tiger-eye-associated allele or were compound heterozygotes. Further, neither variant was detected in 196 horses from four related breeds not known to have the tiger-eye phenotype. Here, we propose that two mutations in SLC24A5 affect iris pigmentation in tiger-eye PRPF horses. Further, unlike OCA6 in humans, the Tiger-eye 1 mutation in its homozygous state or as a compound heterozygote (Tiger-eye 1/Tiger-eye 2) does not appear to cause ocular anomalies or a change in coat color in the PRPF horse.

[1]  J. Arnemann,et al.  Missense Mutation , 2019, Definitions.

[2]  C. Rooryck,et al.  SLC24A5 mutations are associated with non-syndromic oculocutaneous albinism. , 2014, The Journal of investigative dermatology.

[3]  Jaroslav Bendl,et al.  PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations , 2014, PLoS Comput. Biol..

[4]  Arne Ludwig,et al.  Evidence for a Retroviral Insertion in TRPM1 as the Cause of Congenital Stationary Night Blindness and Leopard Complex Spotting in the Horse , 2013, PloS one.

[5]  L. Andersson,et al.  Equine Multiple Congenital Ocular Anomalies and Silver Coat Colour Result from the Pleiotropic Effects of Mutant PMEL , 2013, PloS one.

[6]  Z. Ahmed,et al.  OCA5, a novel locus for non‐syndromic oculocutaneous albinism, maps to chromosome 4q24 , 2013, Clinical genetics.

[7]  A. Wei,et al.  Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism. , 2013, The Journal of investigative dermatology.

[8]  R. Kelsh,et al.  Mutations in c10orf11, a melanocyte-differentiation gene, cause autosomal-recessive albinism. , 2013, American journal of human genetics.

[9]  P. Schnetkamp,et al.  The topology of the C-terminal sections of the NCX1 Na+/Ca2+ exchanger and the NCKX2 Na+/Ca2+-K+ exchanger , 2013, Channels.

[10]  E. G. Cothran,et al.  Genetic Diversity in the Modern Horse Illustrated from Genome-Wide SNP Data , 2013, PloS one.

[11]  J. Matthews,et al.  Mutations in MITF and PAX3 Cause “Splashed White” and Other White Spotting Phenotypes in Horses , 2012, PLoS genetics.

[12]  R. Bellone,et al.  Investigation of HERC2 and OCA2 SNP for iris color variation in puerto rican paso fino horses , 2011 .

[13]  J. Mezey,et al.  Whole-Genome SNP Association in the Horse: Identification of a Deletion in Myosin Va Responsible for Lavender Foal Syndrome , 2010, PLoS genetics.

[14]  H. Kang,et al.  Variance component model to account for sample structure in genome-wide association studies , 2010, Nature Genetics.

[15]  Mats Larsson,et al.  Genetics of human iris colour and patterns , 2009, Pigment cell & melanoma research.

[16]  A. Cecile J.W. Janssens,et al.  Eye color and the prediction of complex phenotypes from genotypes , 2009, Current Biology.

[17]  R. Bellone,et al.  Missense Mutation in Exon 2 of SLC36A1 Responsible for Champagne Dilution in Horses , 2008, PLoS genetics.

[18]  Snæbjörn Pálsson,et al.  Two newly identified genetic determinants of pigmentation in Europeans , 2008, Nature Genetics.

[19]  R. Bellone,et al.  Congenital ocular anomalies in purebred and crossbred Rocky and Kentucky Mountain horses in Canada. , 2008, The Canadian veterinary journal = La revue veterinaire canadienne.

[20]  Kari Stefansson,et al.  ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.

[21]  F. Hu,et al.  A Genome-Wide Association Study Identifies Novel Alleles Associated with Hair Color and Skin Pigmentation , 2008, PLoS genetics.

[22]  D. Rice,et al.  Ocular Albinism and Hypopigmentation Defects in Slc24a5—I— Mice , 2008, Veterinary pathology.

[23]  T. Dadd,et al.  SLC24A5 Encodes a trans-Golgi Network Protein with Potassium-dependent Sodium-Calcium Exchange Activity That Regulates Human Epidermal Melanogenesis* , 2008, Journal of Biological Chemistry.

[24]  Johan T den Dunnen,et al.  Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene. , 2008, American journal of human genetics.

[25]  D. Cox,et al.  A genomewide association study of skin pigmentation in a South Asian population. , 2007, American journal of human genetics.

[26]  Snæbjörn Pálsson,et al.  Genetic determinants of hair, eye and skin pigmentation in Europeans , 2007, Nature Genetics.

[27]  Keith C. Cheng,et al.  SLC24A5, a Putative Cation Exchanger, Affects Pigmentation in Zebrafish and Humans , 2005, Science.

[28]  Tadeusz Sarna,et al.  Melanin in human irides of different color and age of donors. , 2005, Pigment cell research.

[29]  C. Summers,et al.  Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype , 2003, Human Genetics.

[30]  A. Fischer,et al.  Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). , 2003, The Journal of clinical investigation.

[31]  KyeongJin Kang,et al.  Topology of the retinal cone NCKX2 Na/Ca-K exchanger. , 2003, Biochemistry.

[32]  S. Taourit,et al.  A mutation in the MATP gene causes the cream coat colour in the horse , 2003, Genetics Selection Evolution.

[33]  J. Murray,et al.  Linkage of the grey coat colour locus to microsatellites on horse chromosome 25. , 2002, Animal genetics.

[34]  M. Brilliant,et al.  Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. , 2001, American journal of human genetics.

[35]  D. Hu,et al.  Characterization of melanins in human irides and cultured uveal melanocytes from eyes of different colors. , 1998, Experimental eye research.

[36]  J. Mickelson,et al.  Endothelin receptor B polymorphism associated with lethal white foal syndrome in horses , 1998, Mammalian Genome.

[37]  M. Ramsay,et al.  Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene. , 1997, American journal of human genetics.

[38]  I H Wallow,et al.  The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. , 1997, Survey of ophthalmology.

[39]  Wej.  Equine Color Genetics , 1996 .

[40]  E. Zackai,et al.  Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2). , 1994, Human molecular genetics.

[41]  T. Dadd,et al.  NCKX5, a natural regulator of human skin colour variation, regulates the expression of key pigment genes MC1R and alpha-MSH and alters cholesterol homeostasis in normal human melanocytes. , 2013, Advances in experimental medicine and biology.

[42]  R. Bellone,et al.  Congenital stationary night blindness is associated with the leopard complex in the Miniature Horse. , 2012, Veterinary Ophthalmology.